Multinational cost‐effectiveness analysis of empagliflozin for heart failure patients with ejection fraction >40%

por Kolovos, Spyros, Bellanca, Leana, Groyer, Harinala, Rosano, Giuseppe M.C., Solé, Alexandra, Gaultney, Jennifer, Linden, Stephan
Publicado 2023

Economic Impact of Low Adherence to COPD Management Guidelines in Spain

por Miravitlles, Marc, Solé, Alexandra, Aguilar, Helena, Ampudia, Ana, Costa-Samarra, Jaume, Mallén-Alberdi, Maria, Nieves, Diana
Publicado 2021